|
Status |
Public on Mar 07, 2017 |
Title |
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing (ChIP-Seq) |
Organism |
Homo sapiens |
Experiment type |
Genome binding/occupancy profiling by high throughput sequencing
|
Summary |
We performed a transcriptomic and epigenomic study in patient-derived B-cell lines to investigate the genome-scale effects of DNMT3B dysfunction. We highlighted that altered intragenic CpG-methylation impairs multiple aspects of transcriptional regulation, like alternative TSS usage, antisense transcription and exon splicing.
|
|
|
Overall design |
Samples used in this study correspond to B-lymphoblastoid cell lines (B-LCL) derived from peripheral blood of individuals affected by ICF1 syndrome and healthy individuals
|
|
|
Contributor(s) |
Gagliardi M, Angelini C, Matarazzo MR |
Citation(s) |
28334849 |
Submission date |
Mar 06, 2017 |
Last update date |
May 15, 2019 |
Contact name |
Miriam Gagliardi |
E-mail(s) |
miriam_gagliardi@psych.mpg.de
|
Organization name |
Max Planck Institute of Psychiatry
|
Street address |
Kraepelinstrasse 2-10
|
City |
Munich |
State/province |
Bayern |
ZIP/Postal code |
80804 |
Country |
Germany |
|
|
Platforms (2) |
GPL11154 |
Illumina HiSeq 2000 (Homo sapiens) |
GPL13393 |
AB SOLiD 4 System (Homo sapiens) |
|
Samples (20)
|
|
This SubSeries is part of SuperSeries: |
GSE95747 |
ICF-specific DNMT3B dysfunction interferes with intragenic regulation of mRNA transcription and alternative splicing |
|
Relations |
BioProject |
PRJNA378321 |
SRA |
SRP101527 |